文献速递冠心病外科

冠状动脉旁路移植术后支架内再狭窄靶血管的再次血运重建

Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis.
PubMed 文献 · Ann Thorac Surg · 2017-04-02

本研究回顾2001至2014年1668例三支病变行非体外循环冠状动脉旁路移植术(OPCAB)患者,比较有支架史组(259例)与无支架组(1409例)。倾向性评分匹配后两组住院死亡率及14年生存率、MACCE无事件率相似,但无支架组14年靶血管再次血运重建(TVR)无事件率显著更高;支架内再狭窄是晚期TVR和MACCE的独立危险因素。

要点

  • 既往支架史不增加OPCAB远期死亡率。
  • 支架内再狭窄靶血管移植增加再次TVR风险(HR 3.355)。
  • 支架内再狭窄亦增加MACCE风险(HR 1.645)。

核心结论

  • 既往冠状动脉支架置入不增加OPCAB远期死亡率,但移植至支架内再狭窄靶血管增加再次TVR和MACCE风险。

主要发现

  • 匹配后两组住院死亡率均为1.2%(n=3),p>0.999。
  • 14年总生存率无支架组75.6%±6.6% vs 支架组71.9%±8.5%,p=0.917。
  • 14年MACCE无事件率无支架组68.3%±6.6% vs 支架组54.6%±8.5%,p=0.239。
  • 14年TVR无事件率无支架组97.2%±1.7% vs 支架组76.9%±6.5%,p<0.001。
  • 支架内再狭窄是晚期TVR的独立危险因素(HR 3.355,95%CI 1.925-5.848,p<0.001)及MACCE危险因素(HR 1.645,95%CI 1.105-2.448,p=0.014)。

临床怎么用

  • 对既往支架史患者行OPCAB时,应关注靶血管支架内再狭窄,因其增加再次TVR和MACCE风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to examine the impact of previous percutaneous coronary intervention with stent on long-term outcomes after off-pump coronary artery bypass grafting (OPCAB). METHODS: Between January 2001 and December 2014, 1,668 patients with triple-vessel disease undergoing OPCAB were reviewed and divided into 2 groups. The no-stent group (n = 1,409) included patients who underwent OPCAB as a primary revascularization procedure and the stent group (n = 259) included patients with a history of percutaneous coronary intervention with stent. The mean follow-up duration was 5.32 ± 3.39 years. RESULTS: After propensity score matching, characteristics of both groups were comparable (n = 259 in each group). In-hospital mortality (n = 3 [1.2%] in both groups; p > 0.999) was similar. The 14-year overall survival rate (75.6% ± 6.6% in the no-stent group versus 71.9% ± 8.5% in the stent group; p = 0.917) and freedom from major adverse cardiac and cerebrovascular events (MACCEs) rate (68.3% ± 6.6% versus 54.6% ± 8.5%; p = 0.239) were also similar. However, freedom from target vessel revascularization (TVR) rate at 14 years was significantly higher in the no-stent group (97.2% ± 1.7% versus 76.9% ± 6.5%; p < 0.001). The independent risk factor for late TVR was in-stent restenosis (hazard ratio, 3.355; 95% confidence interval, 1.925 to 5.848; p < 0.001) and it also was a risk factor for MACCEs (hazard ratio, 1.645; 95% CI, 1.105 to 2.448; p = 0.014). CONCLUSIONS: Previous intracoronary stenting does not increase long-term mortality, but grafting to previously stented target vessels with in-stent restenosis increases the risk of repeat TVR and MACCEs.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kim JH, Lee SH, Joo HC, et al. Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis. Ann Thorac Surg. 2017. PMID: 28377035. doi:10.1016/j.athoracsur.2017.03.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。